Trial Site Detail

 

Drug:
deepGeneAI-001 + Sintilimab
Trial:
Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment (PCV-GSTT)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Ruijin Hospital

     
Shanghai , 200031
China

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Ruijin Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.